Generic drugs are a congenial way to save drugs without compromising on their quality. For more than a decade, we have been establishing and supporting long-term business relationships with the pharmaceutical companies engaged in generic drugs production. Those are the companies with the most resonating names in the industry: Ajanta Pharma, Cipla Ltd., Ranbaxy Ltd., and many others. Read on if you are interested in how generic drugs can enrich your shopping experience and make your pharmacy bills to much easier on your pocket.

Generic drugs rules explained by Canadian Pharmacy

A generic drug is a medicine that contains the same amount of active ingredient and has the same bioavailability as another brand with an expired patent. (choose Generic Viagra Type for You. How? Find answer here)

The protection offered by the patent allows the company that has incurred the costs of researching and launching an innovative drug to maintain the monopoly in the sale of this drug for a period of several years. At the end of the patent protection period a drug can be produced by other pharmaceutical companies and offered on the market at a lower price.

The definition of an equivalent medicine was introduced recently. The modification of the name is used in order to avoid the possible connotations of the hitherto neutral term “generic” that could be considered in some way reductive for this type of drugs. However, both terms are correct and identify a medicine that contains the same amount of active ingredient and has the same bioavailability as another brand with expired patent.

If with the generic term the accent was placed on the name of the medicine, which is no longer that of the registered trademark but rather that of the active principle followed by that of the manufacturing company, with the equivalent term we want to emphasize the therapeutic equivalence with respect to the drug originator.

Why generics cost less

The generic drug costs less than the originator because research investments have already been recovered during the monopoly period granted by the patent. It is known that to demonstrate the efficacy and therapeutic safety of a new drug it is necessary to test it on hundreds or even thousands of subjects. This testing phase takes months and entails high costs.

The company that markets a generic medicine, on the other hand, is exempted from demonstrating therapeutic efficacy since, if the active ingredient reaches the same levels in the blood obtained from the originator medicine (ie if it is bioequivalent to this), it also presents the same therapeutic efficacy. Demonstrating bioequivalence compared to a drug of known efficacy and safety requires much less time and costs, so the generic drug can be marketed at a lower price.

A decade after the availability of generic drugs, the general practitioner has learned to know them and use them to the fullest. However, in daily clinical practice, some critical issues emerge that directly involve him due to the peculiarity of the doctor-patient relationship intrinsic to family medicine: the family doctor is the fulcrum of the treatment process and it is to it that the patients entrust themselves completely.

The wide availability of expired patent medicines with the same active ingredient can create confusion: the prescription of the generic drug, by now consolidated in terms of efficacy and safety, must be supported then with a particular information to its own patients, that in the setting of the medicine generally they are often elderly and fragile and over time they have memorized some elements identifying branded drugs (trade name, packaging, color of the tablets, etc.). Furthermore, in the prescriptive choice of the generic, the family doctor must manage problems that involve not only its client, but also other health figures, including the medical specialist (for example, it happens that in hospital discharge patients are advised to take that specific “designer” drug) and the pharmacist, who has the possibility of replacing the generic medicine prescribed by the original drug with another of a different brand.

The pharmacist plays a central role in the development and dissemination of the use and culture of the generic drug. In fact, by law, a pharmacy technician is required to inform the patient about the availability on the market of the generic drug corresponding to the originating medicinal product and to inform them about the existing price difference and any quota to be paid if they decide to buy the original

Furthermore, the pharmacist carries out the important task of reassuring the patient about the quality of generic drugs and overlapping therapeutic activity and the incidence of side effects compared to the original drugs.

How is a generic drug evaluated?

As the reference medicinal product has been authorized for several years, information is already available on this subject and therefore no new information is required. The legislation establishes which tests should be conducted to show that the generic drug is as safe and effective as the reference medicine. In most cases, the information provided by a bioequivalence study is sufficient. The bioequivalence study is a study aimed at demonstrating that the amount of active ingredient present in the human body is the same, regardless of whether one takes the generic drug or the reference medicine.

Generic drugs are produced following the same quality standards used for all other medicines.

Furthermore, as for all other medicines, the regulatory authorities carry out periodic inspections on the site or at the production sites.

The safety of all medicines, including generic drugs, is monitored even after the marketing authorization has been issued. Each company is required to set up a system to monitor the safety of the products it puts on the market. Regulatory authorities can also inspect this monitoring system. In general, if specific precautions are required when taking the reference medicine, the same precautions should also be taken for the generic drug.

Generics for Viagra, Cialis, Levitra: the most popular products at Canadian Pharmacy

Although discovered some 20 years ago (actually, even earlier than that), oral drugs against erectile dysfunction (ED) are still regarded as something of a novelty. They are still referred to as lifestyle medications – talk about deeply rooted stereotypes, and although the evidence of sexual health being an integral part of general wellbeing has been piling up, the cost of ED therapy has not yet been included into basic healthcare insurance plan. The cost of Viagra and its analogs remains to be outrageously high; drugs used in ED treatment continue to be in the top tier of medications and are comparable to that of oncology pills. Is this not ridiculous?

It is this state of things that we at Canadian Pharmacy www.mycanadianpharmacyrx.com strongly disagree with and medicate in every way we find possible. In partnership with the giants of generic drug manufacture, we bring you the top quality generics for men’s health. At our pharmacy, you can order the legendary pills like generic Viagra and its analogs: Kamagra, Viagra Professional, Viagra Super Active, Viagra Soft, Kamagra Oral Jelly, Malegra, Fildena, Viagra Super Force; Cialis generics: Cialis Professional, Tadalis, Tadacip, Tadora, and others. Levitra generics are slightly less popular, but they are just as effective – and they have their fans among people who have comorbidity conditions like diabetes to consider.

With our offers, you can order large quantities of generic ED drugs for less money, all while saving on shipping. Did you know that the per-item price nosedives as you order bigger packages of drugs? And your package will be shipped to you for free if you order for $150,00 and above? Apart from this, we also will include 4 bonus pills of either generic Viagra or Cialis for you to try.

Generic pills in ED trial packs

Another congenial solution offered at Canadian Pharmacy is the so-called trial packs containing ED drugs in every possible combination. The problem of choice has been around ever since introduction of the second PDE5 inhibitor to the market, Levitra (vardenafil), back in 2003, and Cialis (tadalafil) shortly after it the same year. Now there has been added another novelty PDE5 inhibitor, Stendra (avanafil), which is approved by the FDA, and Zydena (udenafil) – which has currently only been approved in Asia.

With the differences between the drugs belonging to the same class of vasodilators being minimal, it is almost impossible to choose at times. With the obvious exception of Cialis, this marathoner among ED pills whose therapeutic window is estimated at 36 hours and whose active substance, tadalafil, is unaffected by simultaneous use of alcohol and meals, however abundant, all the other drugs produce similar effects.

How do you choose the best pill? You need to try several ones, preferably, giving each one several tries, in order to pick what’s best for you. The evidence is mostly anecdotal in case of the efficacy of every PDE5 inhibitor drug. And so we have prepared several combinations of ED pills in trial packs: Viagra and Cialis, Viagra, Cialis and Levitra, Viagra and Female Viagra, and then some, for you to have that unique chance to figure out which generic ED drug works best for you. And what’s best, the per-item price becomes so much more attractive when you order a pack!

A note on responsible use of drugs

Canadian Pharmacy reminds you that generic drugs, just as the brand ones, can be sold either on prescription or OTC. Viagra, Cialis, Levitra and their generics are all prescription drugs that require for you to receive a medical consultation before you order them online. If you for some reason cannot get a medical consultation, we will be happy to assist you in connecting you with a licensed healthcare provider.

Always take your medications in adherence to instructions given to you by the prescriber. Self-diagnosing and self-medicating in any form are a dangerous practice that is fraught with more risks than benefits for your health. The information presented on our website is not intended as medical advice or instructions to be followed without prior consulting your GP, but as generally educational and informational materials.